ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 137 filers reported holding ANAPTYSBIO INC in Q4 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $452 | +255.9% | 13,617 | +118.8% | 0.00% | 0.0% |
Q2 2023 | $127 | -5.9% | 6,224 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $135 | -30.1% | 6,224 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $193 | -99.9% | 6,224 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $159,000 | +26.2% | 6,224 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $126,000 | -18.2% | 6,224 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $154,000 | -28.7% | 6,224 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $216,000 | +27.8% | 6,224 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $169,000 | +5.0% | 6,224 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $161,000 | +20.1% | 6,224 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $134,000 | 0.0% | 6,224 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $134,000 | +45.7% | 6,224 | 0.0% | 0.00% | – |
Q3 2020 | $92,000 | -33.8% | 6,224 | 0.0% | 0.00% | -100.0% |
Q2 2020 | $139,000 | +58.0% | 6,224 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $88,000 | -4.3% | 6,224 | +9.8% | 0.00% | 0.0% |
Q4 2019 | $92,000 | -53.5% | 5,666 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $198,000 | -38.1% | 5,666 | 0.0% | 0.00% | -50.0% |
Q2 2019 | $320,000 | – | 5,666 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 3,688,448 | $371,500,000 | 60.25% |
Cormorant Asset Management, LP | 1,251,485 | $126,050,000 | 13.20% |
BVF INC/IL | 594,397 | $59,868,000 | 7.22% |
VHCP Management II, LLC | 282,550 | $28,458,000 | 6.82% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 812,484 | $81,833,000 | 3.22% |
Iguana Healthcare Management, LLC | 40,000 | $4,029,000 | 2.62% |
Perceptive Advisors | 756,387 | $76,183,000 | 2.52% |
Cormorant Asset Management, LP | 135,000 | $13,597,000 | 1.42% |
EAM Global Investors LLC | 21,734 | $2,189,000 | 1.12% |
PFM Health Sciences, LP | 425,896 | $42,896,000 | 1.02% |